U.S. warns of liver risk with Glaxo, Roche diet drugs (Reuters)

Reuters - Weight-loss drugs from GlaxoSmithKline PLC and Roche Holding AG will carry new warnings about rare reports of liver injury, U.S. health officials said on Wednesday.

Read more | Previous | Next